Visceral leishmaniases (VL) or kala-azar is the most dreaded and devastating amongst the
various forms of leishmaniases. The disease, though localized in certain areas only, has …

In public health terms, leishmaniases are diseases of humans and dogs, whereas, in
epidemiological terms, Leishmania spp. are considered to represent infections of a wide …

Aim Visceral leishmaniasis (VL) caused by parasites belonging to genus Leishmania (L.) is
classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis …

A vaccine against different forms of leishmaniasis should be feasible considering the wealth
of information on genetics and biology of the parasite, clinical and experimental immunology …

Visceral leishmaniasis (VL) or kala-azar is a chronic protozoan infection in humans
associated with significant global morbidity and mortality. The causative agent is a …

Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …

Leishmaniasis is a vector-borne disease caused by different species of protozoan parasites
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …

Visceral leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows
endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO …

In vaccination studies, mice have been injected by different routes with living promastigotes
of nonpathogenic leishmania followed by cutaneous challenge with pathogenic …

Leishmaniasis in many ways offers a unique vaccine case study. Two reasons for this are
that leishmaniasis is a disease complex caused by several different species of parasite that …